JP2025510915A5 - - Google Patents
Info
- Publication number
- JP2025510915A5 JP2025510915A5 JP2024557201A JP2024557201A JP2025510915A5 JP 2025510915 A5 JP2025510915 A5 JP 2025510915A5 JP 2024557201 A JP2024557201 A JP 2024557201A JP 2024557201 A JP2024557201 A JP 2024557201A JP 2025510915 A5 JP2025510915 A5 JP 2025510915A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- score
- patient
- dmt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22000085 | 2022-03-27 | ||
| EP22000084.8 | 2022-03-27 | ||
| EP22000085.5 | 2022-03-27 | ||
| EP22000084 | 2022-03-27 | ||
| EP23154014.7 | 2023-01-30 | ||
| EP23153996 | 2023-01-30 | ||
| EP23154014 | 2023-01-30 | ||
| EP23153996.6 | 2023-01-30 | ||
| PCT/EP2023/057874 WO2023186827A1 (en) | 2022-03-27 | 2023-03-27 | 5-methoxy-n,n-dimethyltryptamine for the treatment of postpartum depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510915A JP2025510915A (ja) | 2025-04-15 |
| JP2025510915A5 true JP2025510915A5 (enExample) | 2026-04-10 |
Family
ID=93292078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557201A Pending JP2025510915A (ja) | 2022-03-27 | 2023-03-27 | 産後うつ病の処置のための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250205200A1 (enExample) |
| EP (1) | EP4499080A1 (enExample) |
| JP (1) | JP2025510915A (enExample) |
| KR (1) | KR20240167886A (enExample) |
| CN (1) | CN119156213A (enExample) |
| AU (1) | AU2023242438A1 (enExample) |
| CA (1) | CA3255671A1 (enExample) |
| IL (1) | IL315894A (enExample) |
-
2023
- 2023-03-27 CN CN202380037486.3A patent/CN119156213A/zh active Pending
- 2023-03-27 CA CA3255671A patent/CA3255671A1/en active Pending
- 2023-03-27 AU AU2023242438A patent/AU2023242438A1/en active Pending
- 2023-03-27 KR KR1020247035761A patent/KR20240167886A/ko active Pending
- 2023-03-27 EP EP23717040.2A patent/EP4499080A1/en active Pending
- 2023-03-27 JP JP2024557201A patent/JP2025510915A/ja active Pending
- 2023-03-27 US US18/851,322 patent/US20250205200A1/en active Pending
- 2023-03-27 IL IL315894A patent/IL315894A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yorkston et al. | Propranolol in the control of schizophrenic symptoms | |
| Moller et al. | Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery | |
| Rasmussen | Making the first anti-depressant: amphetamine in American medicine, 1929–1950 | |
| JP2025510914A5 (enExample) | ||
| JP2025511084A5 (enExample) | ||
| JP2025511081A5 (enExample) | ||
| Hoffman et al. | The effectiveness of virtual reality pain control with multiple treatments of longer durations: A case study | |
| JP2025510913A5 (enExample) | ||
| JP2025510295A5 (enExample) | ||
| JP2025510369A5 (enExample) | ||
| JP2025510368A5 (enExample) | ||
| JP2025510916A5 (enExample) | ||
| JP2025512831A5 (enExample) | ||
| Gilbert | Weaving medicine back together: Mind–body medicine in the twenty-first century | |
| Odejide et al. | Traditional healers and mental illness in the city of Ibadan | |
| Bassetti et al. | Poststroke hypersomnia | |
| JP2025510915A5 (enExample) | ||
| Harris | Study: no new SARS-CoV-2 variants in recent outbreak in China | |
| JP2025511072A5 (enExample) | ||
| Zhang et al. | [Retracted] The Application of Focused Care Model in the Management of Hepatitis B Patients in a Tertiary Care Hospital and the Impact on Patients’ Quality of Life | |
| Zalmunin et al. | A comparative study of the clinical efficacy of receptive music therapy in the complex treatment of anxiety and depressive disorders | |
| Thapa et al. | Integrating Yogic Practices to Conventional Medicine in Preventing and Treating Medical Disorders | |
| Marshall et al. | The role of intravenous clomipramine in the treatment of obsessional and phobic disorders | |
| Harris | Teens report record levels of violence, mental health challenges | |
| Harris | Oral health worsened, visits decreased in Medicare beneficiaries |